By Professor Mark Duncan Willcox

Journal articles

Browne K; Kuppusamy R; Walsh WR; Black DSC; Willcox MDP; Kumar N; Chen R, 2023, 'Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms241914966

Duong HT; Phan MAT; Madigan MC; Stapleton F; Wilcsek G; Willcox M; Golebiowski B, 2023, 'Culture of primary human meibomian gland cells from surgically excised eyelid tissue', Experimental Eye Research, 235, pp. 109636, http://dx.doi.org/10.1016/j.exer.2023.109636

Ozkan J; Majzoub ME; Coroneo M; Thomas T; Willcox M, 2023, 'Ocular microbiome changes in dry eye disease and meibomian gland dysfunction', Experimental Eye Research, 235, http://dx.doi.org/10.1016/j.exer.2023.109615

Craig JP; Alves M; Wolffsohn JS; Downie LE; Efron N; Galor A; Gomes JAP; Jones L; Markoulli M; Stapleton F; Starr CE; Sullivan AG; Willcox MDP; Sullivan DA, 2023, 'TFOS Lifestyle Report Executive Summary: A Lifestyle Epidemic - Ocular Surface Disease', Ocular Surface, 30, pp. 240 - 253, http://dx.doi.org/10.1016/j.jtos.2023.08.009

Urmi UL; Attard S; Vijay AK; Willcox MDP; Kumar N; Islam S; Kuppusamy R, 2023, 'Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus', Antibiotics, 12, pp. 1436, http://dx.doi.org/10.3390/antibiotics12091436

Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP, 2023, 'A review of the antiviral activity of cationic antimicrobial peptides', Peptides, 166, http://dx.doi.org/10.1016/j.peptides.2023.171024

Mishra SK; Yasir M; Willcox M; Mishra Baishnab SK, 2023, 'Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern', Lancet Microbe, 4, pp. e482 - e483, http://dx.doi.org/10.1016/S2666-5247(23)00114-3

Chakraborty S; Katsifis G; Roohani I; Boyer C; McKenzie D; Willcox MDP; Chen R; Kumar N, 2023, 'Electrostatic and Covalent Binding of an Antibacterial Polymer to Hydroxyapatite for Protection against Escherichia coli Colonization', Materials, 16, pp. 5045, http://dx.doi.org/10.3390/ma16145045

Cappiello F; Verma S; Lin X; Moreno IY; Casciaro B; Dutta D; McDermott AM; Willcox M; Coulson-Thomas VJ; Mangoni ML, 2023, 'Novel Peptides with Dual Properties for Treating Pseudomonas aeruginosa Keratitis: Antibacterial and Corneal Wound Healing', Biomolecules, 13, pp. 1028, http://dx.doi.org/10.3390/biom13071028

Jones L; Efron N; Bandamwar K; Barnett M; Jacobs DS; Jalbert I; Pult H; Rhee MK; Sheardown H; Shovlin JP; Stahl U; Stanila A; Tan J; Tavazzi S; Ucakhan OO; Willcox MDP; Downie LE, 2023, 'TFOS Lifestyle: Impact of contact lenses on the ocular surface', Ocular Surface, 29, pp. 175 - 219, http://dx.doi.org/10.1016/j.jtos.2023.04.010

Gomes JAP; Azar DT; Baudouin C; Bitton E; Chen W; Hafezi F; Hamrah P; Hogg RE; Horwath-Winter J; Kontadakis GA; Mehta JS; Messmer EM; Perez VL; Zadok D; Willcox MDP, 2023, 'TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface', Ocular Surface, 29, pp. 331 - 385, http://dx.doi.org/10.1016/j.jtos.2023.04.011

Markoulli M; Ahmad S; Arcot J; Arita R; Benitez-del-Castillo J; Caffery B; Downie LE; Edwards K; Flanagan J; Labetoulle M; Misra SL; Mrugacz M; Singh S; Sheppard J; Vehof J; Versura P; Willcox MDP; Ziemanski J; Wolffsohn JS, 2023, 'TFOS Lifestyle: Impact of nutrition on the ocular surface: TFOS Lifestyle Workshop: Nutrition report', Ocular Surface, 29, pp. 226 - 271, http://dx.doi.org/10.1016/j.jtos.2023.04.003

Khan M; Ma K; Wan I; Willcox MD, 2023, 'Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates', Contact Lens and Anterior Eye, 46, pp. 101819, http://dx.doi.org/10.1016/j.clae.2023.101819

Urmi UL; Willcox MDP; Islam S; Kuppusamy R; Vijay AK, 2023, 'Ocular signs and symptoms of monkeypox virus infection, and possible role of the eye in transmission of the virus', Contact Lens and Anterior Eye, 46, pp. 101808, http://dx.doi.org/10.1016/j.clae.2022.101808

Craig JP; Alves M; Wolffsohn JS; Downie LE; Efron N; Galor A; Gomes JAP; Jones L; Markoulli M; Stapleton F; Starr CE; Sullivan AG; Willcox MDP; Sullivan DA, 2023, 'TFOS Lifestyle Report Introduction: A Lifestyle Epidemic - Ocular Surface Disease', Ocular Surface, 28, pp. 304 - 309, http://dx.doi.org/10.1016/j.jtos.2023.04.014

Perez VL; Mah FS; Willcox M; Pflugfelder S, 2023, 'Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review', Journal of Ocular Pharmacology and Therapeutics, 39, pp. 89 - 101, http://dx.doi.org/10.1089/jop.2022.0133

Peguda HK; Lakshminarayanan R; Carnt NA; Gu Z; Willcox MDP, 2023, 'Correction to: The Activity of Polyhomoarginine against Acanthamoeba castellanii (Biology, (2022), 11, 12, (1726), 10.3390/biology11121726)', Biology, 12, pp. 470, http://dx.doi.org/10.3390/biology12030470

Kuppusamy R; Yasir M; Yu TT; Voli F; Vittorio O; Miller MJ; Lewis P; Black DSC; Willcox M; Kumar N, 2023, 'Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm', Antibiotics, 12, pp. 585, http://dx.doi.org/10.3390/antibiotics12030585

Dahal A; Shrestha K; Karki R; Bhattarai S; Aryal S; Deo SK; Regmi B; Willcox M; Mishra SK, 2023, 'Antimicrobial Resistance and Biofilm Production in Uropathogens from Renal Disease Patients Admitted to Tribhuvan University Teaching Hospital, Nepal', Journal of Clinical Pharmacy and Therapeutics, 2023, http://dx.doi.org/10.1155/2023/4867817

Das T; Das B; Young BC; Aldilla V; Sabir S; Almohaywi B; Willcox M; Manefield M; Kumar N, 2023, 'Ascorbic acid modulates the structure of the Pseudomonas aeruginosa virulence factor pyocyanin and ascorbic acid-furanone-30 combination facilitate biofilm disruption', Frontiers in Microbiology, 14, pp. 1166607, http://dx.doi.org/10.3389/fmicb.2023.1166607

Willcox MDP; Bahatheg G; Carnt N; Kalaiselvan P; Kumar N; Kuppusamy R; Rayamajhee B; Sara M; Stapleton F; Vijay AK; Yasir M; Yu TT, 2023, 'Biofilms and contact lenses: problems and solutions', Microbiology Australia, 44, pp. 96 - 99, http://dx.doi.org/10.1071/MA23027

Subedi D; Fang T; Bhusal RP; Willcox M, 2023, 'Editorial: Bacteriophages to treat infections with multidrug resistant pathogens', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1348463

Kalaiselvan P; Dutta D; Konda NV; Sharma S; Kumar N; Stapleton F; Willcox MDP, 2023, 'Effect of Deposition and Protease Digestion on the Ex Vivo Activity of Antimicrobial Peptide-Coated Contact Lenses', Nanomaterials, 13, pp. 349, http://dx.doi.org/10.3390/nano13020349

Kalaiselvan P; Yasir M; Vijay AK; Willcox MDP; Tummanapalli S, 2023, 'Longevity of hand sanitisers on fingers', Clinical and Experimental Optometry, 106, pp. 436 - 442, http://dx.doi.org/10.1080/08164622.2022.2040334

Sabir S; Das T; Kuppusamy R; Yu TT; Willcox MD; Black DSC; Kumar N, 2023, 'Novel quinazolinone disulfide analogues as pqs quorum sensing inhibitors against Pseudomonas aeruginosa', Bioorganic Chemistry, 130, pp. 106226, http://dx.doi.org/10.1016/j.bioorg.2022.106226

Kuppusamy R; Browne K; Suresh D; Do Rosario RM; Chakraborty S; Yang S; Willcox M; Black D; Chen R; Kumar N, 2023, 'Transition Towards Antibiotic Hybrid Vehicles: The Next Generation Antibacterials', Current Medicinal Chemistry, 30, pp. 104 - 125, http://dx.doi.org/10.2174/0929867329666220613105424

Rayamajhee B; Sharma S; Willcox M; Henriquez FL; Rajagopal RN; Shrestha GS; Subedi D; Bagga B; Carnt N, 2022, 'Assessment of genotypes, endosymbionts and clinical characteristics of Acanthamoeba recovered from ocular infection', BMC Infectious Diseases, 22, pp. 757, http://dx.doi.org/10.1186/s12879-022-07741-4

Aldilla VR; Chen R; Kuppusamy R; Chakraborty S; Willcox MDP; Black DSC; Thordarson P; Martin AD; Kumar N, 2022, 'Hydrogels with intrinsic antibacterial activity prepared from naphthyl anthranilamide (NaA) capped peptide mimics', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-26426-1

Peguda HK; Lakshminarayanan R; Carnt NA; Gu Z; Willcox MDP, 2022, 'The Activity of Polyhomoarginine against Acanthamoeba castellanii', Biology, 11, pp. 1726, http://dx.doi.org/10.3390/biology11121726

Peguda HK; Carnt NA; Gu Z; Kumar N; Willcox MDP; Kuppusamy R, 2022, 'The Anti-Amoebic Activity of a Peptidomimetic against Acanthamoeba castellanii', Microorganisms, 10, pp. 2377, http://dx.doi.org/10.3390/microorganisms10122377

Rayamajhee B; Willcox MDP; Henriquez FL; Petsoglou C; Subedi D; Carnt N, 2022, 'Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens', Trends in Parasitology, 38, pp. 975 - 990, http://dx.doi.org/10.1016/j.pt.2022.08.007

Konda N; Chakrabarti S; Garg P; Willcox MDP, 2022, 'Association of Single-Nucleotide Polymorphisms in Interleukin Genes with Microbial Keratitis in a South Indian Population', Pathogens, 11, pp. 1387, http://dx.doi.org/10.3390/pathogens11111387

Dutta D; Stapleton F; Willcox M, 2022, 'Ocular Surface Infection and Antimicrobials', Antibiotics, 11, pp. 1496, http://dx.doi.org/10.3390/antibiotics11111496

Afzal M; Vijay AK; Stapleton F; Willcox M, 2022, 'The Relationship between Ciprofloxacin Resistance and Genotypic Changes in S. aureus Ocular Isolates', Pathogens, 11, pp. 1354, http://dx.doi.org/10.3390/pathogens11111354

Cometta S; Jones RT; Juárez-Saldivar A; Donose BC; Yasir M; Bock N; Dargaville TR; Bertling K; Brünig M; Rakić AD; Willcox M; Hutmacher DW, 2022, 'Melimine-Modified 3D-Printed Polycaprolactone Scaffolds for the Prevention of Biofilm-Related Biomaterial Infections', ACS Nano, 16, pp. 16497 - 16512, http://dx.doi.org/10.1021/acsnano.2c05812

Yasir M; Kumar Vijay A; Willcox M; Vijay A, 2022, 'Antiviral effect of multipurpose contact lens disinfecting solutions against coronavirus', Contact Lens and Anterior Eye, 45, pp. 101513, http://dx.doi.org/10.1016/j.clae.2021.101513

Khosravanihaghighi A; Koshy P; Yasir M; Romanazzo S; Lovric V; Kilian KA; Willcox MD; Walsh WR; Sorrell CC, 2022, 'Production of Antibacterial Activity and Bone Cell Proliferation by Surface Engineering of Ga- or Mn-Doped Ceria-Coated Biomedical Titanium Alloy', Advanced Engineering Materials, 24, http://dx.doi.org/10.1002/adem.202200077

Khan M; McDonald M; Mundada K; Willcox M, 2022, 'Efficacy of Ultraviolet Radiations against Coronavirus, Bacteria, Fungi, Fungal Spores and Biofilm', Hygiene, 2, pp. 120 - 131, http://dx.doi.org/10.3390/hygiene2030010

Alenezi H; Ozkan J; Willcox M; Parnell G; Carnt N, 2022, 'Differential gene expression of the healthy conjunctiva during the day', Contact Lens and Anterior Eye, 45, http://dx.doi.org/10.1016/j.clae.2021.101494

Afzal M; Vijay AK; Stapleton F; Willcox MDP, 2022, 'Genomics of Staphylococcus aureus Strains Isolated from Infectious and Non-Infectious Ocular Conditions', Antibiotics, 11, pp. 1011, http://dx.doi.org/10.3390/antibiotics11081011

Bahatheg G; Kuppusamy R; Yasir M; Black DSC; Willcox M; Kumar N, 2022, 'Short Tryptamine-Based Peptoids as Potential Therapeutics for Microbial Keratitis: Structure-Function Correlation Studies', Antibiotics, 11, pp. 1074, http://dx.doi.org/10.3390/antibiotics11081074

Shahzad S; Willcox M, 2022, 'The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2', Journal of Molecular Evolution, 90, pp. 227 - 230, http://dx.doi.org/10.1007/s00239-022-10054-4

Ozkan J; Willcox M; Coroneo M, 2022, 'A comparative analysis of the cephalic microbiome: The ocular, aural, nasal/nasopharyngeal, oral and facial dermal niches', Experimental Eye Research, 220, pp. 109130, http://dx.doi.org/10.1016/j.exer.2022.109130

Mohid SA; Sharma P; Alghalayini A; Saini T; Datta D; Willcox MDP; Ali H; Raha S; Singha A; Lee DK; Sahoo N; Cranfield CG; Roy S; Bhunia A, 2022, 'A rationally designed synthetic antimicrobial peptide against Pseudomonas-associated corneal keratitis: Structure-function correlation', Biophysical Chemistry, 286, http://dx.doi.org/10.1016/j.bpc.2022.106802

Afzal M; Vijay AK; Stapleton F; Willcox M, 2022, 'Virulence Genes of Staphylococcus aureus Associated With Keratitis, Conjunctivitis, and Contact Lens–Associated Inflammation', Translational Vision Science and Technology, 11, pp. 5, http://dx.doi.org/10.1167/tvst.11.7.5

Sarwat S; Stapleton FJ; Willcox MDP; O’mara PB; Tilley RD; Gooding JJ; Roy M, 2022, 'Feasibility of Silicon Quantum Dots as a Biomarker for the Bioimaging of Tear Film', Nanomaterials, 12, pp. 1965, http://dx.doi.org/10.3390/nano12121965

Wu J; Yu TT; Kuppusamy R; Hassan MM; Alghalayini A; Cranfield CG; Willcox MDP; Black DS; Kumar N, 2022, 'Cholic Acid-Based Antimicrobial Peptide Mimics as Antibacterial Agents', International Journal of Molecular Sciences, 23, pp. 4623, http://dx.doi.org/10.3390/ijms23094623

Asiedu K; Markoulli M; Bonini S; Bron AJ; Dogru M; Kwai N; Poynten A; Willcox MDP; Krishnan AV, 2022, 'Tear film and ocular surface neuropeptides: Characteristics, synthesis, signaling and implications for ocular surface and systemic diseases', Experimental Eye Research, 218, http://dx.doi.org/10.1016/j.exer.2022.108973

Efron N; Morgan PB; Nichols JJ; Walsh K; Willcox MD; Wolffsohn JS; Jones LW, 2022, 'All soft contact lenses are not created equal', Contact Lens and Anterior Eye, 45, pp. 101515, http://dx.doi.org/10.1016/j.clae.2021.101515

Vazquez Campos X; Damnjanovic D; Bridge W; Elliot L; Willcox M, 2022, 'Characterisation of Bacteriophage vB_SmaM_Ps15 Infective to Stenotrophomonas maltophilia Clinical Ocular Isolates', Viruses, 14, pp. 709 - 709, http://dx.doi.org/10.3390/v14040709

Back to profile page